Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Onychomycosis Treatment Market
Onychomycosis Treatment Market Share
- Report ID: GMI5089
- Published Date: Aug 2021
- Report Format: PDF
Onychomycosis Treatment Market Share
Some of the prominent players operating in the market include
- Pfizer Inc.
- Novartis AG
- Johnson & Johnson Services Inc.
- Medimetriks Pharmaceuticals Inc.
- Bausch Health Sciences
- Galderma Laboratories
- Moberg Pharma AB
- Dr. Reddy’s Laboratories Ltd
- Merz Pharma
- Kaken Pharmaceutical Co. Ltd
- GlaxoSmithKline plc
- Taro Pharmaceuticals Industries Ltd.
These participants are implementing various growth strategies to sustain industry competition.
Frequently Asked Questions (FAQ) :
The market size of onychomycosis treatment surpassed USD 4.2 billion in 2020 and will expand at a CAGR of 5.6% between 2021 and 2027.
Distal subungual onychomycosis accounted for 68% of the market share in 2020 and will grow as DSO is the most common type of onychomycosis.
Allylamine will register a growth rate of 5.4% from 2021 to 2027 due to the rising availability and deployment of such drugs.
North America market captured 40% of revenue share in 2020 and will grow owing to the surgical awareness about onychomycosis infection and the availability of numerous treatment alternatives.
Onychomycosis Treatment Market Scope
×
Get a free sample of
Onychomycosis Treatment Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below